News for Futura Medical plc (FAMDF)

Sep 10, 2024 / 08:00AM GMTPresentationSep 10, 2024 / 08:00AM GMT =====================Corporate Participants===================== * James Barder Futura

Apr 10, 2024 / 08:00AM GMTOperator Good morning and welcome to the Futura Medical PLC for your results investor presentation. (Operator Instructions) Before we

Futura Medical PLC - Guildford, England-based pharmaceutical company focused on sexual health products - Confirms that lead product Eroxon will from March 1 be available on prescription in England...

Futura Medical PLC on Monday said that it has extended its exclusive licensing agreement with Cooper Consumer Health Group, a European self-care organisation, to January 2029. The Guildford,...

The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: ---------- Luceco PLC - London-based lighting...

Futura Medical PLC - Guildford, Surrey-based pharmaceutical company - Says that it has launched Exoron in the United Arab Emirates. Exoron, or MED3000, is a topical gel used to treat erectile...

Futura Medical PLC - Guildford, Surrey-based pharmaceutical company - Receives European patent for erectile dysfunction treatment, MED3000, until 2040. Continues to pursue patent applications to...

The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: ---------- Elixirr International PLC - London-based consultancy -...

SkyQuest projects that the erectile dysfunction market will attain a USD 4.73 billion value by 2030, with a CAGR of 8.5% over the forecast period...

Futura Medical PLC - Surrey, England-based pharmaceutical company - Says its distribution partner, Labatec Pharma, received regulatory approval for MED3000 in Saudi Arabia. MED3000 is Futura's...

/PRNewswire/ -- The erectile dysfunction (ED) drugs market size is forecast to increase by USD 1.20 billion from 2021 to 2026, at a CAGR of 6.1%, according to...

/PRNewswire/ -- The Erectile Dysfunction (ED) Drugs Market value is set to grow by USD 1.20 billion, progressing at a CAGR of 6.1% from 2021 to 2026, as per...